﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Cision News</title><link>https://news.cision.com</link><description>Cision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations.</description><pubDate>Wed, 10 Jun 2026 01:19:52 GMT</pubDate><image><title>Cision News</title><width>146</width><height>60</height><link>https://news.cision.com</link><url>https://news.cision.com/Content/img/news-logo.png</url></image><item><title>GE Healthcare hosts European Media Summit in Berlin</title><link>https://news.cision.com/ge-healthcare/r/ge-healthcare-hosts-european-media-summit-in-berlin,c299000</link><guid isPermaLink="false">cision176554</guid><description><![CDATA[Berlin, September 12, 2007 – GE Healthcare is hosting its second European media Summit in Berlin, Germany. Under this year’s theme, The future of healthcare: Europe at the Crossroads, the annual gathering brings together healthcare reporters from across Western and Eastern Europe with leading healthcare luminaries.
Over 100 participants will attend the two day event that will focus on the challenges and cost of a growing Europe on the region’s healthcare systems. This year’s speakers include;
· Reinaldo Garcia, President & CEO, GE Healthcare International – The Future of Healthcare: Europe]]></description><pubDate>Wed, 12 Sep 2007 07:01:20 GMT</pubDate></item><item><title>Survey of Senior European Healthcare Policy Makers reveals widespread support for increased investment in Early Health</title><link>https://news.cision.com/ge-healthcare/r/survey-of-senior-european-healthcare-policy-makers-reveals-widespread-support-for-increased-investment-in-early-health,c298999</link><guid isPermaLink="false">cision176552</guid><description><![CDATA[Respondents say balance between Early Health measures – prevention, screening, early diagnosis - and treatment is not optimal.
Berlin, September 12, 2007 - A new survey of senior healthcare policy makers and advisors across the European Union, announced today at GE Healthcare’s media summit in Berlin, shows widespread support for an increase in Early Health initiatives such as prevention, screening and early diagnosis, but not at the expense of current healthcare budgets allocated for treatment.
The qualitative research carried out in August 2007 by Total Healthcare Solutions on behalf of]]></description><pubDate>Wed, 12 Sep 2007 07:00:07 GMT</pubDate></item><item><title>DISCLOSURE NOTICE</title><link>https://news.cision.com/ge-healthcare/r/disclosure-notice,c225824</link><guid isPermaLink="false">cision147203</guid><description><![CDATA[Chalfont St. Giles, United Kingdom and Uppsala, Sweden - Goldcup D 1879 AB, under change of name to GE Healthcare Holding AB (“GE Healthcare”), has today acquired 9,462,094 shares and 631,425 warrants to subscribe for shares in Biacore International AB (publ) (“Biacore”) from its parent company GE Medical Holding AB. If the warrants are exercised, GE Healthcare will hold approximately 97 per cent of the shares in Biacore on a fully diluted basis. # # # For further information, please contact: GE Healthcare Sweden c/o Sund Kommunikation Eva Reftmark (+46 768 663 844) eva.reftmark@]]></description><pubDate>Tue, 15 Aug 2006 17:10:27 GMT</pubDate></item><item><title>DISCLOSURE NOTICE</title><link>https://news.cision.com/ge-healthcare/r/disclosure-notice,c225822</link><guid isPermaLink="false">cision147201</guid><description><![CDATA[Chalfont St. Giles, United Kingdom and Uppsala, Sweden - GE Medical Holding AB has today transferred 9,462,094 shares and 631,425 warrants to subscribe for shares in Biacore International AB (publ) (“Biacore”) to its wholly-owned subsidiary Goldcup D 1879 AB, under change of name to GE Healthcare Holding AB. GE Medical Holding AB no longer owns any shares or warrants in Biacore after the transfer. # # # For further information, please contact: GE Healthcare Sweden c/o Sund Kommunikation Eva Reftmark (+46 768 663 844) eva.reftmark@sundkommunikation.se GE Healthcare Val Jones (+44 7917 175]]></description><pubDate>Tue, 15 Aug 2006 17:09:09 GMT</pubDate></item><item><title>GE HEALTHCARE TO COMPLETE THE ACQUISITION OF BIACORE</title><link>https://news.cision.com/ge-healthcare/r/ge-healthcare-to-complete-the-acquisition-of-biacore,c225634</link><guid isPermaLink="false">cision147112</guid><description><![CDATA[GE Healthcare today announced that pursuant to its public offer it has received acceptances equivalent to approximately 98% of the total number of shares outstanding in Biacore. All of the conditions to the offer have been fulfilled and GE Healthcare is proceeding with the closing of the offer.
Chalfont St. Giles, United Kingdom and Uppsala, Sweden - GE Healthcare, acting through GE Medical Holding AB (“GE Healthcare”), announced that it is proceeding with its public offer for Biacore International AB (publ) (“Biacore”) (the “Offer”). As at the close of the acceptance period under the Offer]]></description><pubDate>Mon, 14 Aug 2006 21:48:17 GMT</pubDate></item><item><title>GE Healthcare today publishes an addendum to the Biacore offer document</title><link>https://news.cision.com/ge-healthcare/r/ge-healthcare-today-publishes-an-addendum-to-the-biacore-offer-document,c223525</link><guid isPermaLink="false">cision146367</guid><description><![CDATA[Chalfont St. Giles, United Kingdom and Uppsala – 24 July 2006 – The document constitutes an addendum to the offer document that was approved and registered by the Swedish Financial Supervisory Authority on 7 July 2006, regarding the offer to the shareholders in Biacore International AB (publ) for the acquisition of shares by GE Medical Holding AB. The addendum has been prepared with reference to, and includes, Biacore International AB’s interim report for the period January – June 2006. The addendum will be available on GE Healthcare’s website, www.gehealthcare.com. # # #]]></description><pubDate>Mon, 24 Jul 2006 12:57:18 GMT</pubDate></item><item><title>GE Healthcare today publishes the offer document in relation to the recommended cash offer to the shareholders of Biacore</title><link>https://news.cision.com/ge-healthcare/r/ge-healthcare-today-publishes-the-offer-document-in-relation-to-the-recommended-cash-offer-to-the-shareholders-of-biacore,c221980</link><guid isPermaLink="false">cision145778</guid><description><![CDATA[Chalfont St. Giles, United Kingdom and Uppsala – 7 July 2006 – The offer document relating to GE Healthcare’s recommended cash offer to the shareholders of Biacore International AB (publ) is available in English and in Swedish on www.gehealthcare.com. # # # For further information, please contact: GE Healthcare Sweden c/o Sund Kommunikation Eva Reftmark (+46 768 663 844) eva.reftmark@sundkommunikation.se GE Healthcare - International Val Jones (+44 7917 175 192) val.jones@ge.com GE Healthcare - Americas Kristin Silady (+1 732 322 4452) kristin.silady@ge.com UBS Investment Bank – Financial]]></description><pubDate>Fri, 07 Jul 2006 13:40:05 GMT</pubDate></item><item><title>GE Healthcare Announces Recommended Cash Offer of SEK330 per share in Biacore. Expands GE Healthcare’s presence in Life Sciences</title><link>https://news.cision.com/ge-healthcare/r/ge-healthcare-announces-recommended-cash-offer-of-sek330-per-share-in-biacore--expands-ge-healthcare-s-presence-in-life-sciences,c219054</link><guid isPermaLink="false">cision144525</guid><description><![CDATA[Chalfont St. Giles, United Kingdom and Uppsala, Sweden - 20 June 2006 - GE Healthcare, a unit of General Electric Company (NYSE: GE), today announced its intention to acquire Biacore International AB (“Biacore”) (SSE: BCOR), a leading provider of life science tools for protein research. Pursuant to this transaction, GE Healthcare will initiate a tender offer to acquire all of the outstanding shares of Biacore for SEK330 per share, payable in cash, for a total consideration of approximately SEK2.9 billion (approximately U.S.$390 million) on a fully diluted basis, net of Biacore cash and]]></description><pubDate>Tue, 20 Jun 2006 07:55:07 GMT</pubDate></item><item><title>GE Healthcare Announces Recommended Cash Offer of SEK330 per Share in Biacore</title><link>https://news.cision.com/ge-healthcare/r/ge-healthcare-announces-recommended-cash-offer-of-sek330-per-share-in-biacore,c219039</link><guid isPermaLink="false">cision144513</guid><description><![CDATA[GE Healthcare, a unit of General Electric Company (NYSE: GE), through the wholly owned subsidiary GE Medical Holding AB, today announces a recommended cash offer to the shareholders of Biacore International AB (publ) (SSE: BCOR) (“Biacore” or the “Company”) to tender all their shares to GE Healthcare (the “Offer”). Biacore is listed on the O-list, Attract 40, of the Stockholm Stock Exchange (Stockholmsbörsen) (the “SSE”).
Summary ? GE Healthcare offers SEK330 per share in Biacore * ? The Offer represents a premium of 35 per cent relative to the volume weighted average share price of SEK245]]></description><pubDate>Tue, 20 Jun 2006 07:34:28 GMT</pubDate></item></channel></rss>